|
5 Companies |
|
1 Product |
|
1 Product |
|
2 Mechanisms of Action |
|
0 Trials |
|
13 News |
|
- ||||||| Trial completion, Trial primary completion date: Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment (clinicaltrials.gov) - Feb 21, 2016
P3, N=113, Completed, Sponsor: G&E Herbal Biotechnology Co., LTD
Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Nov 2015
- |||| Trial primary completion date: Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment (clinicaltrials.gov) - Aug 14, 2015
P3, N=113, Recruiting, Sponsor: G&E Herbal Biotechnology Co., LTD
Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Nov 2015 Trial primary completion date: Jun 2015 --> Mar 2016
- |||| ingenol mebutate / Generic mfg.
Trial completion: Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses (clinicaltrials.gov) - Mar 23, 2015
P2, N=60, Completed, Sponsor: Peplin
Trial primary completion date: Jun 2015 --> Mar 2016 No longer recruiting --> Completed
- Trial primary completion date: Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis (clinicaltrials.gov) - May 1, 2014
P=N/A, N=40, Completed, Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
No longer recruiting --> Completed Trial primary completion date: Oct 2013 --> Nov 2013
- Trial completion: Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis (clinicaltrials.gov) - May 1, 2014
P=N/A, N=40, Completed, Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Trial primary completion date: Oct 2013 --> Nov 2013 Recruiting --> Completed
- |||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Trial completion: Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis (clinicaltrials.gov) - Feb 22, 2014
P4, N=551, Completed, Sponsor: Graceway Pharmaceuticals, LLC
Recruiting --> Completed No longer recruiting --> Completed
- |||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Trial completion: Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands (clinicaltrials.gov) - Feb 22, 2014
P4, N=270, Completed, Sponsor: Graceway Pharmaceuticals, LLC
No longer recruiting --> Completed No longer recruiting --> Completed
- |||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Trial completion: Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses (clinicaltrials.gov) - Feb 22, 2014
P4, N=60, Completed, Sponsor: Derm Research @ 888 Inc.
No longer recruiting --> Completed No longer recruiting --> Completed
- Enrollment open: Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis (clinicaltrials.gov) - Apr 23, 2013
P=N/A, N=40, Recruiting, Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Clinical: A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses (clinicaltrials.gov) - Dec 22, 2011
P=N/A, N=410, Completed, Sponsor: Actavis Mid-Atlantic LLC
- |||||||||| New P3 trial: Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment (clinicaltrials.gov) - Dec 14, 2011
P3, N=113, Recruiting, Sponsor: G&E Herbal Biotechnology Co., LTD